ESTIMATED
05/07/2024
05/07/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.19 | -$0.19 | -$0.19 |
Q2 2024 | 2 | -$0.20 | -$0.18 | -$0.19 |
Q3 2024 | 0 | -$0.17 | -$0.17 | -$0.17 |
Q4 2024 | 0 | -$0.16 | -$0.16 | -$0.16 |
ClearPoint Neuro, Inc. last posted its earnings results on Tuesday, May 7th, 2024. The company reported $-0.16 earnings per share for the quarter, topping analysts' consensus estimates of $-0.19 by $0.03. The company had revenue of 7.64 M for the quarter and had revenue of 23.96 M for the year. ClearPoint Neuro, Inc. has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -6.63. ClearPoint Neuro, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/07/2024 | Q1 2024 | -$0.19 | -$0.16 | 0.03 | $6.99 M | $7.64 M | 03/12/2024 | Q4 2023 | -$0.22 | -$0.19 | 0.03 | $6.53 M | $6.81 M | 11/09/2023 | Q3 2023 | -$0.25 | -$0.20 | 0.05 | $5.76 M | 08/08/2023 | Q2 2023 | -$0.18 | -$0.29 | -0.11 | $5.95 M | 05/11/2023 | Q1 2023 | -$0.18 | -$0.22 | -0.04 | $5.00 M | $5.43 M | 03/01/2023 | Q4 2022 | -$0.22 | -$0.18 | 0.04 | $5.20 M | $5.17 M | 11/08/2022 | Q3 2022 | -$0.19 | -$0.15 | 0.04 | $5.15 M | 08/09/2022 | Q2 2022 | -$0.18 | $5.20 M | 05/11/2022 | Q1 2022 | -$0.20 | -$0.17 | 0.03 | $5.03 M | 03/08/2022 | Q4 2021 | -$0.18 | $4.30 M | $4.28 M | 11/09/2021 | Q3 2021 | -$0.18 | $4.00 M | $4.57 M | 08/12/2021 | Q2 2021 | -$0.17 | $3.69 M | $3.41 M | 05/11/2021 | Q1 2021 | -$0.15 | -$0.13 | 0.02 | $4.03 M | 03/22/2021 | Q4 2020 | -$0.09 | $3.24 M | $3.72 M | 11/12/2020 | Q3 2020 | -$0.09 | $2.47 M | $3.52 M | 08/13/2020 | Q2 2020 | -$0.11 | $1.88 M | $2.48 M | 05/13/2020 | Q1 2020 | -$0.13 | $3.12 M | 03/27/2020 | Q4 2019 | -$0.11 | $3.21 M | 11/13/2019 | Q3 2019 | -$0.08 | $2.93 M | 08/12/2019 | Q2 2019 | -$0.13 | $2.61 M |
---|
A. ClearPoint Neuro, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. In the previous quarter, ClearPoint Neuro, Inc. (NASDAQ:CLPT) reported $-0.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.19 by $0.03.
A. The conference call for ClearPoint Neuro, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for ClearPoint Neuro, Inc.'s latest earnings report can be read online.
A. ClearPoint Neuro, Inc. (NASDAQ:CLPT) has a recorded annual revenue of $23.96 M.
A. ClearPoint Neuro, Inc. (NASDAQ:CLPT) has a recorded net income of $23.96 M. ClearPoint Neuro, Inc. has generated $-0.9 earnings per share over the last four quarters.
A. ClearPoint Neuro, Inc. (NASDAQ:CLPT) has a price-to-earnings ratio of -6.63 and price/earnings-to-growth ratio is -0.32.